Enkephalinase and endorphinase inhibitors as anti-craving compositions
Patent 4761429 Issued on August 2, 1988. Estimated Expiration Date: August 2, 2005. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
A new class of anti-craving compositions is provided by substances which inhibit breakdown of endogenous substances such as enkephalins and/or endorphins. An anti-alcohol craving effect is observed with an enkephalin breakdown inhibitor. Specifically, D-phenylalanine, DL-phenylalanine, D-leucine, DL-leucine, and hydrocinnamic acid, each an encephalin breakdown inhibitor, significantly lowered alcohol intake in animals and humans. The anti-alcohol desire effect is observed in animals genetically prone to choose alcohol over water solutions.
Other References
Goldstein and Judson, Science, 172:290-292 (Apr. 1971)
Miceli, Eur. J. Pharmacol., 63:327-33 (1980)
Jorgensen and Hole, Eur. J. Pharmacol., 75:223-229 (1981)
Jorgensen and Hole, Eur. J. Pharmacol., 125:249-56 (1986)
Catley, Lancet 1263 (Jun. 6, 1981)
Altschuler, et al., Pharmacol., Biochem. & Behav., 14:97-100
Galizio, et al., Alcohol, 1:197-200 (1984)
Nuotto, et al., Acta Pharmacol. Toxicol. 54:278-84 (1984)
Lignian, et al., Human Toxicol., 2:221-25 (1983)
Ewing and McCarty, Alcoholism, 7:271-5 (1983)
Hemningsen and Sorenson, Acta Pharmacol. et. Toxicol, 46:62-65 (1980)
August 2, 2005. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
